Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events—A Comprehensive Review

by Josefien W. Hommes, Rik J. Verheijden, Karijn P. M. Suijkerbuijk, Dörte Hamann, Dörte Hamann
Published 2021-02-01

Lower risk of severe checkpoint inhibitor toxicity in more advanced disease

by Anne M May, Michel W J M Wouters, Ellen Kapiteijn, John B A G Haanen, Christian U Blank, Maureen J B Aarts, Rik J Verheijden, Astrid A M van der Veldt, Marye J Boers-Sonderen, Franchette W P J van den Berkmortel, Alfonsus J M van den Eertwegh, Jan Willem B de Groot, Jacobus J M van der Hoeven, Geke A P Hospers, Djura Piersma, Rozemarijn S van Rijn, Albert J ten Tije, Gerard Vreugdenhil, Michiel C T van Zeijl, Karijn P M Suijkerbuijk
Published 2020-12-01